Fortune 10 pharmaceutical client launches new drug successfully using Resonance

SITUATION
Current pharmaceutical client received FDA approval for a "Priority review" of a new drug that could potentially save thousands of lives a year from a fatal immune disease. The client contracted G&G.- based on powerful insights about doctors’ motivations from previous work.

INSIGHTS
The doctors shared several expected issues such as safety and efficacy but also revealed emotions and motivations towards this potential new treatment that were new and unexpected. Issues of insurance company pressure and hospital management policies were disclosed as well as emotional and motivational information that will help the client launch the new drug effectively.

IMPLICATIONS
Client could now target doctors most likely to adopt the new treatment based on Motivational Segmentation. Sales could use the insights to draft qualifying questions and maximize sales efforts. Marketing could use Resonance data to develop branding, ad copy and packaging consistent with motivational insights.

RESULTS
Stay tuned, the full marketing strategy based on Resonance findings will be deployed pending FDA approval on the new drug.